Corrigendum to: Immune profile of obese people and in vitro effects of red grape polyphenols on peripheral blood mononuclear cells (Oxidative Medicine and Cellular Longevity (2017) 2017 (9210862) DOI: 10.1155/2017/9210862);Immune Profile of Obese People and in Vitro Effects of Red Grape Polyphenols on Peripheral Blood Mononuclear Cells

Oxidative Medicine and Cellular Longevity

Volumn 2017, Issue , 2017, Pages

  Magrone, Thea ^a   Jirillo, Emilio ^a,b   Spagnoletta, Anna ^a   Magrone, Manrico ^a   Russo, Matteo Antonio ^c   Fontana, Sergio ^d   Laforgia, Flavia ^d   Donvito, Ilaria ^a   Campanella, Angelo ^a   Silvestris, Franco ^a   De Pergola, Giovanni ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Fondazione San Raffaele   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d Farmalabor Srl   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CONTROL THEORY; GLYCOPROTEINS;

GRAPE POLYPHENOLS; H CONTROLS; INTERFERON-GAMMA; INTERLEUKIN-2; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHORBOL MYRISTATE ACETATES; POLYPHENOLS; TUMOR NECROSIS FACTOR ALPHA;

INTERFERONS;

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; PHORBOL 13 ACETATE 12 MYRISTATE; POLYPHENOL; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; GRAPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MIDDLE AGED; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; TH17 CELL; ERRATUM; ERROR;

CELLS; POLYPHENOLS;

EID: 85063709075     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/4589705     Document Type: Erratum

References (47)

1. S. Mitchell and D. Shaw, "The worldwide epidemic of female obesity," Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 29, no. 3, pp. 289-299, 2015.
2. T. Magrone and E. Jirillo, "Childhood obesity: immune response and nutritional approaches," Frontiers in Immunology, vol. 6, article 76, 2015.
3. A. T. McGill, "Past and future corollaries of theories on causes of metabolic syndrome and obesity related co-morbidities part 2: a composite unifying theory review of human-specific coadaptations to brain energy consumption," Archives of Public Health, vol. 72, no. 1, p. 31, 2014.
4. V. G. DeMarco, A. R. Aroor, and J. R. Sowers, "The pathophysiology of hypertension in patients with obesity," Nature Reviews Endocrinology, vol. 10, no. 6, pp. 364-376, 2014.
5. G. De Pergola and F. Silvestris, "Obesity as a major risk factor for cancer," Journal of Obesity, vol. 2013, Article ID 291546, 11 pages, 2013.
6. V. Simone, M. D'Avenia, A. Argentiero et al. , "Obesity and breast cancer:molecular interconnections and potential clinical applications," Oncologist, vol. 21, no. 4, pp. 404-417, 2016.
7. M. F. Gregor and G. S. Hotamisligil, "Inflammatory mechanisms in obesity," Annual Review of Immunology, vol. 29, pp. 415-445, 2011.
8. P. Krinninger, R. Ensenauer, K. Ehlers et al. , "Peripheral monocytes of obese women display increased chemokine receptor expression and migration capacity," Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 7, pp. 2500-2509, 2014.
9. T. Magrone and E. Jirillo, "Function and malfunction of the immune cell-adipocyte axis and its modulation by natural products and probiotics," Clinical Immunology Endocrine & Metabolic Drugs, vol. 3, no. 1, pp. 39-46, 2016.
10. R. L. Travers, A. C. Motta, J. A. Betts, A. Bouloumié, and D. Thompson, "The impact of adiposity on adipose tissue-resident lymphocyte activation in humans," International Journal of Obesity, vol. 39, no. 5, pp. 762-769, 2015.
11. R. W. Grant and V. D. Dixit, "Adipose tissue as an immunological organ," Obesity, vol. 23, no. 3, pp. 512-518, 2015.
12. J. B. Pandolfi, A. A. Ferraro, I. Sananez et al. , "ATP-induced inflammation drives tissue-resident Th17 cells in metabolically unhealthy obesity," Journal of Immunology, vol. 196, no. 8, pp. 3287-3296, 2016.
13. M. Fabrizi, V. Marchetti, M. Mavilio et al. , "IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting tregs in adipose tissue and systemic insulin sensitivity," Diabetes, vol. 63, no. 6, pp. 2086-2096, 2014.
14. A. Yoshimura, S. Ohnishi, C. Orito et al. , "Association of peripheral total and differential leukocyte counts with obesityrelated complications in young adults," Obesity Facts, vol. 8, no. 1, pp. 1-16, 2015.
15. L. Ziegler-Heitbrock, "The CD14+ CD16+ blood monocytes: their role in infection and inflammation," Journal of Leukocyte Biology, vol. 81, no. 3, pp. 584-592, 2007.
16. C. Poitou, E. Dalmas, M. Renovato et al. , "CD14CD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis," Arteriosclerosis,Thrombosis, and Vascular Biology, vol. 31,no. 10, pp. 2322-2330, 2011.
17. E. Dalmas, K. Clément, and M. Guerre-Millo, "Defining macrophage phenotype and function in adipose tissue," Trends in Immunology, vol. 32, no. 7, pp. 307-314, 2011.
18. M. J. Kraakman, A. J. Murphy, K. Jandeleit-Dahm, and H. L. Kammoun, "Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function" Frontiers in Immunology, vol. 5, article 470, 2014.
19. R. Meckenstock and A. Therby, "Modifications of immunity in obesity: the impact on the risk of infection," La Revue de Médecine Interne, vol. 36, no. 11, pp. 760-768, 2015.
20. S. E. Wozniak, L. L. Gee, M. S. Wachtel, and E. E. Frezza, "Adipose tissue: the new endocrine organ A review article," Digestive Diseases and Sciences, vol. 54, no. 9, pp. 1847-1856, 2009.
21. R. Watson, V. Preedy, and S. Zibaldi, Polyphenols in Human Health and Disease, vol. 1-2, Elsevier,NewYork,NY, USA, 2014.
22. G. Marzulli, T. Magrone, K. Kawaguchi, Y. Kumazawa, and E. Jirillo, "Fermented grape marc (FGM): immunomodulating properties and its potential exploitation in the treatment of neurodegenerative diseases," Current Pharmaceutical Design, vol. 18, no. 1, pp. 43-50, 2012.
23. T. Magrone, A. Tafaro, F. Jirillo, L. Amati, E. Jirillo, and V. Covelli, "Elicitation of immune responsiveness against antigenic challenge in age-related diseases: effects of red wine polyphenols," Current PharmaceuticalDesign, vol. 14,no. 26,pp. 2749-2757, 2008.
24. G. Marzulli, T. Magrone, L. Vonghia et al. , "Immunomodulating and anti-allergic effects of negroamaro and koshu vitis vinifera fermented grape marc (FGM)," Current Pharmaceutical Design, vol. 20, no. 6, pp. 864-868, 2014.
25. T. Magrone, M. A. Panaro, E. Jirillo, and V. Covelli, "Molecular effects elicited in vitro by red wine on human healthy peripheral blood mononuclear cells: potential therapeutical application of polyphenols to diet-related chronic diseases," Current Pharmaceutical Design, vol. 14, no. 26, pp. 2758-2766, 2008.
26. C. Ricordi, M. Garcia-Contreras, and S. Farnetti, "Diet and inflammation: possible effects on immunity, chronic diseases, and life span," Journal of the American College of Nutrition, vol. 34, supplement 1, pp. 10-13, 2015.
27. A. Ŕos-Hoyo, M. J. Cortés, H. Ŕos-Ontiveros, E. Meaney, G. Ceballos, and G. Gutiérrez-Salmeán, "Obesity, metabolic syndrome, and dietary therapeutical approaches with a special focus on nutraceuticals (polyphenols): a mini-review," International Journal for Vitamin and Nutrition Research, vol. 84, no. 3-4, pp. 113-123, 2015.
28. I. Moreno-Indias, L. Sánchez-Alcoholado, P. Pérez-Martnez et al. , "Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients," Food & Function, vol. 7, no. 4, pp. 1775-1787, 2016.
29. K. F. F. S. Albuquerque, M. P. Marinovic, A. C. Morandi, A. P. Bolin, and R. Otton, "Green tea polyphenol extract in vivo attenuates inflammatory features of neutrophils from obese rats," European Journal of Nutrition, vol. 55, no. 3, pp. 1261-1274, 2016.
30. N. Molina, A. P. Bolin, and R. Otton, "Green tea polyphenols change the profile of inflammatory cytokine release from lymphocytes of obese and lean rats and protect against oxidative damage," International Immunopharmacology, vol. 28, no. 2, pp. 985-996, 2015.
31. M. Roselli, A. Lovece, C. Bruno et al. , "Antioxidant activity of Uva di Troia Canosina: comparison of two extraction methods," Clinical Immunology, Endocrine &Metabolic Drugs, vol. 2, no. 1, pp. 8-12, 2015.
32. T.-D. Kanneganti and V. D. Dixit, "Immunological complications of obesity," Nature Immunology, vol. 13, no. 8, pp. 707-712, 2012.
33. N. Arenas-Ramirez, J. Woytschak, and O. Boyman, "Interleukin-2: biology, design and application," Trends in Immunology, vol. 36, no. 12, pp. 763-777, 2015.
34. J. Y. Lee, J. Ye, Z. Gao et al. , "Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids," The Journal of Biological Chemistry, vol. 278, no. 39, pp. 37041-37051, 2003.
35. P. D. Cani, R. Bibiloni, C. Knauf et al. , "Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice," Diabetes, vol. 57, no. 6, pp. 1470-1481, 2008.
36. C. Bogdan, "Nitric oxide synthase in innate and adaptive immunity: an update," Trends in Immunology, vol. 36, no. 3, pp. 161-178, 2015.
37. S. R. Shaikh, K. M. Haas, M. A. Beck, and H. Teague, "The effects of diet-induced obesity on B cell function," Clinical and Experimental Immunology, vol. 179, no. 1, pp. 90-99, 2015.
38. S. Pradeepan, G. Garrison, and A. E. Dixon, "Obesity in asthma: approaches to treatment," Current Allergy and Asthma Reports, vol. 13, no. 5, pp. 434-442, 2013.
39. T. Gharibi, J. Majidi, T. Kazemi, R. Dehghanzadeh,M. Motallebnezhad, and Z. Babaloo, "Biological effects of IL-21 on different immune cells and its role in autoimmune diseases," Immunobiology, vol. 221, pp. 357-367, 2016.
40. M. Sarra, F. Pallone, and G. Monteleone, "Interleukin-21 in chronic inflammatory diseases," BioFactors, vol. 39, no. 4, pp. 368-373, 2013.
41. N. H. Knudsen and C.-H. Lee, "IL-21 and IRF4: a complex partnership inimmune and metabolic regulation," Diabetes, vol. 63, no. 6, pp. 1838-1840, 2014.
42. J. F. Cavallari, E. Denou, K. P. Foley, W. I. Khan, and J. D. Schertzer, "Different Th17 immunity in gut, liver, and adipose tissues during obesity: the role of diet, genetics, and microbes," Gut Microbes, vol. 7, no. 1, pp. 82-89, 2016.
43. T. Magrone, M. Galantino, N. Di Bitonto, L. Borraccino, G. Chiaromonte, and E. Jirillo, "Effects of thermal water inhalation in chronic upper respiratory tract infections in elderly and young patients," Immunity and Ageing, vol. 13, no. 1, article no. 18, 2016.
44. T. Magrone and E. Jirillo, "Intestinal regulatory T cells: their function and modulation by dietary nutrients," Nutritional Therapy & Metabolism, vol. 32, no. 4, pp. 157-165, 2014.
45. I. Peluso, D. V. Villano, S. A. Roberts et al. , "Consumption of mixed fruit-juice drink and vitamin C reduces postprandial stress induced by a high fat meal in healthy overweight subjects," Current Pharmaceutical Design, vol. 20, no. 6, pp. 1020-1024, 2014.
46. S. Aharoni, Y. Lati, M. Aviram, and B. Fuhrman, "Pomegranate juice polyphenols induce a phenotypic switch in macrophage polarization favoring aM2 anti-inflammatory state," BioFactors, vol. 41, no. 1, pp. 44-51, 2015.
47. M. Zielínska-Przyjemska and A. Dobrowolska-Zachwieja, "Effect of tea polyphenols on oxidative metabolism of polymorphonulear neutrophils in healthy and obese people," Polski Merkuriusz Lekarski, vol. 19, no. 109, pp. 41-47, 2005.